Influence of different factors on endometrial thickness.
Conditions
Interventions
Intervention 1: Intervention group: Patients receiving Estradiol Valerate 2 mg(Brand name: Abu Reihan estradiol valerate, Abu Reihan pharmaceuticals) 2 tablets TDS plus vaginal sildenafil 50 mg(Brand
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Patients undergoing IVF who did not conceive according to the standard uterine preparation protocol 2.Having two frozen embryos or more
Exclusion criteria
Exclusion criteria: Hypertension(HTN) treated with nitrates Cerebrovascular accident(CVA) Thrombophilia Using drugs with nitrate derivatives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial Thickness. Timepoint: Day 14 of the menstrual cycle at the time of routine endometrial preparation protocol and after receiving vaginal sildenafil as TDS with 2 mg estradiol valerate as TDS. Method of measurement: Sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gravidity. Timepoint: At the beginning of study. Method of measurement: Oral question.;Chemical pregnancy rate. Timepoint: After performing the intervention on the study groups. Method of measurement: B-HCG serum level measurement.;Abortion. Timepoint: Clinical symptoms in favor of loss of pregnancy products. Method of measurement: Sonography and Clinical exam based. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz Ettehdi
Oroumia University of Medical Sciences
Outcome results
None listed